Cooperative Agreement U48DP006960
Award Date 9/30/25
Completion Date 9/29/29
Dollars Obligated $349K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Madison, WI, USA
Similar Awards
- The University of Wisconsin System was awarded a $1,266,635 Cooperative Agreement on September 15, 2025 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) to conduct a three-arm comparative effectiveness study on scaling up Medications for Opioid Use Disorder (MOUD) in 120 prisons across 12 states. The project will evaluate the effectiveness of policy levers and multisite learning collaboratives as scale-up implementation approaches to increase...
- The University of Wisconsin System, through its University of Wisconsin - Madison division, has been awarded a $1,042,225.00 Project Grant by the National Institute of Justice (NIJ) under the Comprehensive Opioid, Stimulant, and other Substances Use Program (COSSUP). The grant, with an award date of January 1, 2024 and an ultimate completion date of December 31, 2026, aims to develop and validate an accessible methamphetamine enantiomer-specific identification and quantification method, and...
- The City of Madison, WI received a $1,600,000 Project Grant award from the U.S. Department of Justice's Bureau of Justice Assistance under the Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838). The grant aims to reduce overdose deaths in Dane County, WI by expanding access to treatment, recovery, and support services. Key activities include expanding drug take-back programs, increasing diversion activities, creating a self-referral pathway for individuals on...
- This federal Cooperative Agreement award of $349,997, provided by the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136), supports the Regents of the University of Minnesota's efforts to expand access to low-barrier buprenorphine in acute care settings. The project aims to enhance best practice model fidelity and implement prehospital innovations to...
- The University of Wisconsin System has been awarded a $2,400,345.00 Project Grant under the High Intensity Drug Trafficking Areas (HIDTA) Program (CFDA 95.001) by the Executive Office of the President's Office of the National Drug Control Policy. This federal grant funding will support the University's efforts to reduce drug trafficking and drug production in the United States through coordinated enforcement activities and information sharing among federal, state, local, and Tribal law...
- The Wisconsin Department of Justice (WI DOJ) was awarded a $7,000,000 Comprehensive Opioid, Stimulant, and Substance Abuse Program (COSSUP) grant from the U.S. Department of Justice's Bureau of Justice Assistance. The project aims to reduce the impact of opioid, stimulant, and substance misuse in Wisconsin by expanding pre-arrest diversion programs, implementing technology solutions, and conducting comprehensive evaluations. Key activities include: Awarding up to $500,000 each to 10 new...
- The University of Wisconsin System was awarded a $1,555,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on population modeling to optimize equitable ovarian cancer outcomes. The grant project will take place in Madison, WI from April 15, 2025 to April 14, 2029. This federal grant program supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
- This $350,000 Cooperative Agreement award was provided by the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) on September 30, 2025. The award will support research and coordination to expand access to Medications for Opioid Use Disorder (MOUD) for patients in emergency departments over a 4-year period through September 29, 2029. The University of...
- The University of Utah was awarded a $700,000 Cooperative Agreement from the Centers for Disease Control and Prevention's Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) on September 30, 2025. The award, titled "Randomized Trial: Optimizing Pregnancy and Treatment Interventions for Moms (OPTI-MOM) 3.0," will support a 5-year research project focused on developing, implementing, and evaluating effective practices for preventing injuries and...
- The Department of Health Services (DHS) of the State of Wisconsin was awarded a $570,443 Cooperative Agreement under the Centers for Disease Control and Prevention's (CDC) Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116). The 5-year award, effective January 1, 2025 through December 31, 2029, will support Wisconsin's efforts to prevent, control, and eventually eliminate tuberculosis (TB) in the state and across the United States. The funding will enhance...